Topic

Michigan

A collection of 518 issues

How to Get Evrysdi (Risdiplam) Covered by Humana in Michigan: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Evrysdi (Risdiplam) Covered by Humana in Michigan Yes, Humana covers Evrysdi (risdiplam) with prior authorization. Submit PA through your neurologist with genetic SMA confirmation, baseline motor assessments, and treatment history. Humana decides within 72 hours for standard requests. If denied, you have 65 days to appeal internally,

Renewing Naglazyme (Galsulfase) Approval with Aetna (CVS Health) in Michigan: 2025 Timeline and Documentation Guide

Quick Answer: Renewing Your Naglazyme Coverage Start renewal 60-90 days before expiration. Contact your metabolic specialist to update functional assessments (6-minute walk test, stair climbing capacity) and prepare a medical necessity letter documenting continued clinical benefit. Submit through CVS Specialty Pharmacy or CoverMyMeds portal. If denied, you have 180 days

Aetna's Coverage Criteria for Hemlibra (emicizumab-kxwh) in Michigan: What Counts as "Medically Necessary"?

Answer Box: Getting Hemlibra Covered by Aetna in Michigan Aetna requires prior authorization for Hemlibra (emicizumab-kxwh) with medical necessity established through confirmed hemophilia A diagnosis, routine prophylaxis indication, and hematologist prescription. Michigan patients have strong appeal rights through DIFS external review within 127 days of denial. First step today: Contact

Kuvan (Sapropterin) Coverage with Blue Cross Blue Shield Michigan: Complete Prior Authorization and Appeals Guide 2025

Quick Answer: Getting Kuvan Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Kuvan (sapropterin dihydrochloride) with Tier 2 specialty drug status. You'll need a metabolic geneticist's prescription, documented PKU diagnosis, proof of ≥20% phenylalanine reduction after trial, and active phenylalanine-restricted

How to Get Strimvelis Gene Therapy Covered by Humana in Michigan: Coding, Appeals, and Authorization Guide

Answer Box: Getting Strimvelis Covered by Humana in Michigan Strimvelis requires prior authorization from Humana using ICD-10 code D81.1 (ADA-deficient SCID) and unclassified HCPCS codes C9399 or J3590 since it lacks a specific J-code. Submit PA requests to Humana National Transplant Network at 866-421-5663 or fax 502-508-9300. If denied,

Xembify Approval with Blue Cross Blue Shield in Michigan: Answers to the Most Common Questions

Answer Box: Getting Xembify Covered by Blue Cross Blue Shield in Michigan Xembify (immune globulin, SC) requires prior authorization from Blue Cross Blue Shield of Michigan for primary immunodeficiency. Your fastest path to approval: (1) Have your doctor submit a PA request with your PID diagnosis, low IgG labs, and

If Vitrakvi (Larotrectinib) Isn't Approved by Blue Cross Blue Shield of Michigan: Formulary Alternatives & Exception Paths

Answer Box: Quick Path Forward If Blue Cross Blue Shield of Michigan denies Vitrakvi (larotrectinib), you have three main options: try the covered NTRK inhibitor alternative (entrectinib/Rozlytrek if on formulary), request a formulary exception with documented medical necessity, or appeal the denial. Start by checking your specific plan'

How to Get Tegsedi (inotersen) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (inotersen) Covered by Cigna in Michigan Tegsedi (inotersen) for hATTR polyneuropathy requires prior authorization from Cigna through Express Scripts, REMS program enrollment, and specialty pharmacy dispensing via Accredo. Michigan patients have strong appeal rights through DIFS external review (127 days to file after final denial). Start

How to Get Stelara (Ustekinumab) Covered by Cigna in Michigan: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Stelara (Ustekinumab) Approved by Cigna in Michigan Cigna requires prior authorization for all Stelara prescriptions. Submit a drug-specific PA form with documented prior therapy failures and disease severity scores. If denied, you have 180 days to appeal internally, then 127 days to file external review with Michigan

How to Get Mavenclad (Cladribine) Covered by Aetna CVS Health in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Aetna CVS Health in Michigan Mavenclad (cladribine tablets) requires prior authorization from Aetna CVS Health for relapsing MS coverage. Key requirements: documented failure of ≥2 DMTs, baseline lymphocyte count ≥800 cells/μL, neurologist prescriber, and comprehensive safety screening. Submit PA via Aetna provider portal